Reviewing ASP Isotopes (NASDAQ:ASPI) & Northern Technologies International (NASDAQ:NTIC)

Northern Technologies International (NASDAQ:NTIC) and ASP Isotopes (NASDAQ:ASPI) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Insider & Institutional Ownership

32.9% of Northern Technologies International shares are owned by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are owned by institutional investors. 24.3% of Northern Technologies International shares are owned by insiders. Comparatively, 21.4% of ASP Isotopes shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent recommendations for Northern Technologies International and ASP Isotopes, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Northern Technologies International	0	0	0	0	0.00
ASP Isotopes	0	0	2	0	3.00

ASP Isotopes has a consensus target price of $7.75, indicating a potential downside of 30.93%. Given ASP Isotopes’ stronger consensus rating and higher possible upside, analysts plainly believe ASP Isotopes is more favorable than Northern Technologies International.

Volatility & Risk

Northern Technologies International has a beta of 0.3, indicating that its stock price is 70% less volatile than the S&P 500. Comparatively, ASP Isotopes has a beta of 3.36, indicating that its stock price is 236% more volatile than the S&P 500.

Earnings & Valuation

This table compares Northern Technologies International and ASP Isotopes”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Northern Technologies International	$85.06 million	0.88	$5.41 million	$0.30	26.37
ASP Isotopes	$4.14 million	249.09	-$32.33 million	($0.61)	-18.39

Northern Technologies International has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than Northern Technologies International, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Northern Technologies International and ASP Isotopes’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Northern Technologies International	3.46%	3.38%	2.66%
ASP Isotopes	-2,181.62%	-239.22%	-98.70%

Summary

Northern Technologies International beats ASP Isotopes on 9 of the 14 factors compared between the two stocks.

About Northern Technologies International

Northern Technologies International Corporation develops and markets rust and corrosion inhibiting solutions in North America, South America, Europe, Asia, the Middle East and internationally. It offers rust and corrosion inhibiting products, such as plastic and paper packaging, liquids, coatings, rust removers, cleaners, diffusers, and engineered solutions designed for the oil and gas industry under the ZERUST brand. The company provides a portfolio of bio-based and certified compostable polymer resin compounds and finished products under the Natur-Tec brand. In addition, it offers on-site and technical consulting for rust and corrosion prevention issues. It sells its products and services to automotive, electronics, electrical, mechanical, military, retail consumer, and oil and gas markets through direct sales force, network of independent distributors, agents, manufacturer's sales representatives, and strategic partners. The company was founded in 1970 and is headquartered in Circle Pines, Minnesota.

About ASP Isotopes

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.